<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03920501</url>
  </required_header>
  <id_info>
    <org_study_id>TELESCOPE</org_study_id>
    <nct_id>NCT03920501</nct_id>
  </id_info>
  <brief_title>Comparison of Tele-Critical Care Versus Usual Care On ICU Performance (TELESCOPE)</brief_title>
  <acronym>TELESCOPE</acronym>
  <official_title>Comparison of Tele-Critical Care Versus Usual Care On ICU Performance: A Cluster Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Israelita Albert Einstein</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      TELESCOPE will be a cluster randomized clinical trial to ascertain whether the use of an&#xD;
      intervention including multidisciplinary round with a board certified physician through&#xD;
      tele-critical care and periodic meetings to discuss strategies to improve quality indicators&#xD;
      can reduce ICU length of stay of patients admitted to intensive care units (ICUs).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cluster randomized trial involving ICUs in Brazil. ICU is the unit of randomization.&#xD;
&#xD;
      The trial will have two stages:&#xD;
&#xD;
      Stage I - Baseline data:&#xD;
&#xD;
        -  Characterize participant ICUs and quality indicators&#xD;
&#xD;
        -  Characterize patients from each participant ICU to describe baseline outcomes&#xD;
&#xD;
      Stage II - Intervention:&#xD;
&#xD;
      This is the main stage for data analysis. ICUs will be randomly assigned to an experimental&#xD;
      or control group. The experimental group should use a multidisciplinary rounds with a board&#xD;
      certified physician through tele-critical care and take part in meetings to discuss how to&#xD;
      improve local quality indicators, and the control group will follow the local standard of&#xD;
      care.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 5, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">April 7, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensive Care Unit Length of Stay</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Time until discharge from the intensive care unit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-Hospital Mortality</measure>
    <time_frame>From date of randomization until the date of hospital discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Any death during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standardized Resource Use</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Calculated based on length of stay in the intensive care unit and adjusted for severity of acute illness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Standardized Mortality Rate</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Ratio of observed deaths to expected deaths</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence Density of Central Line-Associated Bloodstream Infection (CLABSI)</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Following the Centers for Disease Control/National Healthcare Safety Network (CDC/NHSN) Surveillance Definition of Healthcare-Associated Infection 2019</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence Density of Ventilator-Associated Pneumonia (VAP)</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Following the Centers for Disease Control/National Healthcare Safety Network (CDC/NHSN) Surveillance Definition of Healthcare-Associated Infection 2019</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence Density of Urinary Tract Infection Associated with Catheter</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Following the Centers for Disease Control/National Healthcare Safety Network (CDC/NHSN) Surveillance Definition of Healthcare-Associated Infection 2019</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-Free Days at Day 28</measure>
    <time_frame>28 Days</time_frame>
    <description>Survival time free of invasive mechanical ventilation from ICU admission to day 28.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Days Receiving Oral or Enteral Feeding</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Use of enteral or oral feeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-Days Under Light Sedation or Alert and Calm</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Defined as a Richmond Agitation-Sedation Scale (RASS) -3 to +1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Patients Under Normoxia</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Defined as oxygen saturation (SpO2) between 92% and 96%</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of Patients with Head of the Bed Elevated</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>30 degrees in patients under mechanical ventilation</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Early Reintubation</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Less than 48 hours after extubation</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Accidental Extubation</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Rate of accidental extubation</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of Central-Line Catheter Use</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Use of central-line catheter use</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of Vesical Catheter Use</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Use of vesical catheter</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of Adequate Prophylaxis for Venous Thromboembolism</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Adequate prophylaxis for venous thromboembolism</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of Adequate Glycemic Control</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Adequate glycemic control</description>
  </other_outcome>
  <other_outcome>
    <measure>ICU Readmission</measure>
    <time_frame>From date of randomization until the date of hospital discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>Readmission less than 24 hours after discharge</description>
  </other_outcome>
  <other_outcome>
    <measure>ICU Mortality</measure>
    <time_frame>From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days</time_frame>
    <description>ICU mortality rate</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">19360</enrollment>
  <condition>Critical Care</condition>
  <condition>Intensive Care Unit</condition>
  <arm_group>
    <arm_group_label>Tele-Critical Care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tele-Critical Care + Audit &amp; Feedback.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tele-Critical Care</intervention_name>
    <description>Daily multidisciplinary rounds with a board certified physician through tele-critical care focusing on: 1) diagnosis; 2) active problems; and 3) therapeutic goals. In addition, the management of health care quality indicators will be conducted by a specially trained (Science of Improvement) board-certified intensive care physician.</description>
    <arm_group_label>Tele-Critical Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Clusters:&#xD;
&#xD;
          -  Intensive care units from public hospitals and with at least eight beds&#xD;
&#xD;
          -  Intensive care units with physician and nurses available 24 hours a day&#xD;
&#xD;
        Exclusion Criteria for Clusters:&#xD;
&#xD;
          -  Intensive care units with structured multidisciplinary round more than three times a&#xD;
             week based in a formal instrument&#xD;
&#xD;
          -  Intensive care units already doing audit &amp; feedback&#xD;
&#xD;
          -  Dedicated coronary care units/cardiac intensive care units or other specialized units&#xD;
&#xD;
          -  Step-down units&#xD;
&#xD;
        Inclusion Criteria for Patients:&#xD;
&#xD;
          -  Adult patients (&gt; 18 years old)&#xD;
&#xD;
          -  Admitted after the beginning of the study&#xD;
&#xD;
        Exclusion Criteria for Patients:&#xD;
&#xD;
          -  Admission for other reasons than medical (e.g., judicial cause)&#xD;
&#xD;
          -  Previously included in TELESCOPE (for the primary outcome analysis)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adriano J Pereira, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Israelita Albert Einstein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Israelita Albert Einstein</name>
      <address>
        <city>SÃ£o Paulo</city>
        <zip>05652-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critical care</keyword>
  <keyword>Quality improvement</keyword>
  <keyword>Tele-critical care</keyword>
  <keyword>Telemedicine</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data sharing open to researchers not members of the study after two years of the publication of the main study</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After two years of the first publication</ipd_time_frame>
    <ipd_access_criteria>Data will be acessed through an online repository protected with password and for secondary analyses according to pre-specified plans.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT03920501/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

